Clinical Chemistry Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1195-1198, 2003; 10.1373/49.7.1195
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zetterberg, H.
Right arrow Articles by Blennow, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zetterberg, H.
Right arrow Articles by Blennow, K.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1195-1198.)
© 2003 American Association for Clinical Chemistry, Inc.


Technical Briefs

The Transcobalamin (TC) Codon 259 Genetic Polymorphism Influences Holo-TC Concentration in Cerebrospinal Fluid from Patients with Alzheimer Disease

Henrik Zetterberg1,a, Ebba Nexö2, Björn Regland3, Lennart Minthon4, Roberta Boson4, Mona Palmér1, Lars Rymo1 and Kaj Blennow1,5

1 Department of Clinical Chemistry and Transfusion Medicine,
3 Institute of Clinical Neuroscience, Psychiatry Section, and
5 Institute of Clinical Neuroscience, Department of Experimental Neuroscience, Sahlgrenska University Hospital, Göteborg University, S-413 45 Gothenburg, Sweden

2 Department of Clinical Biochemistry, AKH, Aarhus University Hospital, DK 8000 Aarhus C, Denmark

4 Neuropsychiatric Clinic, Malmö University Hospital, S-205 02 Malmö, Sweden

aauthor for correspondence: fax 46-31-828458, e-mail henrik.zetterberg@clinchem.gu.se

The first 300 words of the full text of this article appear below.

Two proteins bind vitamin B12 in plasma: haptocorrin (transcobalamin I) and transcobalamin (transcobalamin II; TC). The latter is the critical transporter that delivers vitamin B12 to peripheral tissues. TC carries one-third of the circulating B12 (holo-TC), but most TC is unsaturated (apo-TC) (1)(2). Polyacrylamide gel electrophoresis has revealed two common TC isotypes, M and X, and two rare variants, S and F (3)(4), that may influence the cellular availability of vitamin B12 (5)(6). The phenotypic variability is a multifactorial phenomenon that probably includes cell-type-specific processing of translated TC (5), but the substitution of proline (P) for arginine (R) at codon 259 of the TC gene is the major determinant of the TC variability, at least in Caucasians (5)(7), and affects TC concentrations in plasma (5)(8). Most 259PP individuals have the TC M phenotype, whereas most 259RR individuals have the X phenotype.

Vitamin B12 is essential for the function of the central nervous system (CNS) (9). Little is known about vitamin B12 transport in the human brain, but early in vitro data indicate that TC plays a central role (10). Cerebrospinal fluid (CSF) contains both haptocorrin and TC, with the latter predominating (11). The CSF:plasma ratio of TC is high compared with other plasma proteins (12), which suggests an active transport mechanism or synthesis by cells in the CNS. Cultured astrocytes have been shown to produce and secrete TC in vitro (13), indicating that at least some of the TC in CSF originates from within the CNS. However, because vitamin B12 is not synthesized in human cells, it must enter the brain and CSF from the blood across the . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
J. Med. Genet.Home page
J.-L. Gueant, N. W Chabi, R.-M. Gueant-Rodriguez, O. M Mutchinick, R. Debard, C. Payet, X. Lu, C. Villaume, J.-P. Bronowicki, E. V Quadros, et al.
Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2)
J. Med. Genet., June 1, 2007; 44(6): 363 - 367.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Wuerges, G. Garau, S. Geremia, S. N. Fedosov, T. E. Petersen, and L. Randaccio
Structural basis for mammalian vitamin B12 transport by transcobalamin
PNAS, March 21, 2006; 103(12): 4386 - 4391.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Refsum, C. Johnston, A. B. Guttormsen, and E. Nexo
Holotranscobalamin and Total Transcobalamin in Human Plasma: Determination, Determinants, and Reference Values in Healthy Adults
Clin. Chem., January 1, 2006; 52(1): 129 - 137.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.